Ngā hua rapu - J‐A Johnson
- E whakaatu ana i te 1 - 19 hua o te 19
-
1
-
2
-
3
-
4
Intrarenal Role of Angiotensin II mā Ronald H. Freeman, James O. Davis, Stephen J. Vitale, J. A. Johnson
I whakaputaina 1973Artigo -
5
-
6
-
7
-
8
-
9
Testing Spatiotemporal Hypothesis of Bacterial Evolution Using Methicillin-Resistant Staphylococcus aureus ST239 Genome-wide Data within a Bayesian Framework mā Rebecca Gray, Andrew J. Tatem, J A Johnson, Alexander V. Alekseyenko, Oliver G. Pybus, Marc A. Suchard, Marco Salemi
I whakaputaina 2010Artigo -
10
-
11
Patient-to-Patient Transmission Is Important in Extended-Spectrum -Lactamase-Producing Klebsiella pneumoniae Acquisition mā Anthony D. Harris, Eli N. Perencevich, J. Kristie Johnson, David L. Paterson, J. Glenn Morris, Shiela M. Strauss, J A Johnson
I whakaputaina 2007Artigo -
12
-
13
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1 mā Laurie E. Comstock, David R. Maneval, Pinaki Panigrahi, Aaron Joseph, M. M. Levine, James B. Kaper, J. Glenn Morris, J. A. Johnson
I whakaputaina 1995Artigo -
14
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy mā Stuart A. Scott, Katrin Sangkuhl, E E Gardner, Catherine M. Stein, Jean‐Sébastien Hulot, J. A. Johnson, D M Roden, Teri E. Klein, Alan R. Shuldiner
I whakaputaina 2011Artigo -
15
Plasma Renin Activity Predicts Blood Pressure Responses to -Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension mā S. T. Turner, G. L. Schwartz, Arlene B. Chapman, Amber L. Beitelshees, John G. Gums, Rhonda M. Cooper‐DeHoff, Eric Boerwinkle, J. A. Johnson, Kent R. Bailey
I whakaputaina 2010Artigo -
16
Cholera in Lima, Peru, Correlates with Prior Isolation of Vibrio cholerae from the Environment mā Augusto A. Franco, Alan Fix, Ana Prada, Eduar Bravo Paredes, Juan Carlos Palomino, Anita C. Wright, J. A. Johnson, Robert McCarter, Humberto Guerra, J. Glenn Morris
I whakaputaina 1997Artigo -
17
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing mā J. A. Johnson, Li Gong, Michelle Whirl‐Carrillo, Brian F. Gage, Stuart A. Scott, C. Michael Stein, J. L. Anderson, Stephen E. Kimmel, M T M Lee, Munir Pirmohamed, Mia Wadelius, Teri E. Klein, Russ B. Altman
I whakaputaina 2011Artigo -
18
Molecular Characterization of Gentamicin-Resistant <i>Enterococci</i> in the United States: Evidence of Spread from Animals to Humans through Food mā Susan Donabedian, L A Thal, Ellie Hershberger, Mary Beth Perri, Joseph W. Chow, Paul C. Bartlett, Ronald N. Jones, Kevin Joyce, Shannon Rossiter, K. Gay, J A Johnson, C. Mackinson, Emilio DeBess, Jamie C. Madden, Frederick J. Angulo, Marcus Zervos
I whakaputaina 2003Artigo -
19
The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response mā Kathleen M. Giacomini, Christopher M. A. Brett, Russ B. Altman, N L Benowitz, M. Eileen Dolan, David A. Flockhart, J. A. Johnson, Daniel F. Hayes, Teri E. Klein, Ronald M. Krauss, Deanna L. Kroetz, Howard L. McLeod, Anne Nguyen, Mark J. Ratain, Mary V. Relling, Victor I. Reus, Dan M. Roden, Cathy Schaefer, Alan R. Shuldiner, Todd C. Skaar, Kelan G. Tantisira, Rachel F. Tyndale, L Wang, Richard M. Weinshilboum, Scott T. Weiss, Issam Zineh
I whakaputaina 2007Revisão
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Medicine
Genetics
Gene
Internal medicine
Microbiology
Bacteria
Genotype
Endocrinology
Blood pressure
Cholera
El Tor
Pharmacogenetics
Pharmacology
Renin–angiotensin system
Vibrio cholerae
Vibrionaceae
Kidney
Pharmacogenomics
Plasma renin activity
Renal artery
Antibiotic resistance
Antibiotics
Atrial fibrillation
Bay
Biochemistry
Bioinformatics
Chemistry
Clinical pharmacology
Clopidogrel